Crowell Talks Tax: Recent Developments with the Inflation Reduction Act (VIDEO)
Client Alert | 11 min read | 02.28.24
Tax partner and co-chair Christine Lane and tax partner Carina Federico discuss recent developments with the Inflation Reduction Act.
Key Takeaways:
- Monetization of tax credits;
- Unpacking the bonus credits;
- Timeline of finalized transferability regulations; and
- Using the tax portal and the importance of pre-filing
Previous Videos:
Contacts
Partner
She/Her/Hers
Insights
Client Alert | 4 min read | 03.25.25
Federal Circuit Affirms Deductibility of Hatch-Waxman Litigation Expenses
In a significant decision for generic drug manufacturers, the Federal Circuit recently affirmed that litigation expenses incurred in defending Hatch-Waxman patent lawsuits are deductible as ordinary and necessary business expenses under the Internal Revenue Code (IRC). The ruling in Actavis Laboratories FL, Inc. v. United States, No. 23-1320 (Fed. Cir. Mar. 21, 2025), resolves a key tax dispute, allowing tax deductions for these expenses in the year they are incurred rather than capitalizing them over time. This outcome provides clarity and potential tax benefits for qualifying businesses navigating the interplay of patent litigation and FDA drug approvals.
Client Alert | 4 min read | 03.24.25
USPTO Finds Claims of Two of Moderna’s mRNA Patents Unpatentable: What’s Next in the Vaccine Wars?
Client Alert | 2 min read | 03.21.25
Client Alert | 4 min read | 03.21.25
